Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53,041,500
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
22,781,399
-
Shares change
-
-1,769,957
-
Total reported value, excl. options
-
$55,357,566
-
Value change
-
-$1,193,678
-
Put/Call ratio
-
55%
-
Number of buys
-
40
-
Number of sells
-
53
-
Price
-
$2.43
Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q3 2025
As of 30 Sep 2025 Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) had 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 22,781,399 shares of stock of the company.
Largest 10 holders included CAS Investment Partners, LLC, VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, KPS Global Asset Management UK Ltd, 683 Capital Management, LLC, WORLDLY PARTNERS MANAGEMENT, LLC, Quinn Opportunity Partners LLC, BlackRock, Inc., RBF Capital, LLC, and JANE STREET GROUP, LLC.
This table shows 124 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.